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Abstract
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) often produce Panton–Valentine leukocin (PVL), which is
encoded by two co-transcribed genes located on lysogenized bacteriophages. Six PVL-encoding temperate phages have been described
and single nucleotide polymorphisms (SNPs) in the PVL genes have been reported. In the present study, 22 PVL-positive CA-MRSA iso-
lates were chosen to reﬂect the diversity of multilocus sequence type (MLST) clonal complexes (CC) identiﬁed in our hospital. Isolates
were characterized by antimicrobial resistance proﬁle, staphylococcal cassette chromosome mec (SCCmec) and spa type, pulsed-ﬁeld
gel electrophoresis proﬁle and MLST. Primers were designed to sequence the lukSF-PV genes. PVL-encoding phages were characterized
using a PCR-based assay. SNPs were identiﬁed at seven locations in the lukSF-PV genes, which varied with S. aureus MLST lineage. One
SNP was nonsynonymous. All CC80 and some CC1 isolates carried FSa2mw; CC8, CC88 and CC154 isolates harboured PVL-encoding
elongated head-type phages; and some CC59 isolates harboured a FSa2958-like phage. Novel or variant phages were present in CC5
and some CC1 and CC59 isolates. The PVL gene sequence and the PVL-encoding phage varied with lineage. Further work is required
to determine whether PVL sequence and/or phage variations result in biological differences.
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Introduction
Since the 1990s, community-associated methicillin-resistant
Staphylococcus aureus (CA-MRSA) have emerged worldwide
[1,2]. CA-MRSA tend to affect individuals of all ages in com-
munity settings, are typically susceptible to most non-b-lac-
tam antimicrobials, have diverse genetic backgrounds, carry
small versions (usually types IV or V) of staphylococcal cas-
sette chromosome mec (SCCmec), often encode Panton–Val-
entine leukocidin (PVL), and may be highly virulent [1,3,4].
However, CA-MRSA are an increasingly common cause of
healthcare-associated infection in areas of high prevalence
[5,6] and multidrug-resistant CA-MRSA have been reported
[7,8]. Although the role of PVL as a virulence determinant
has been questioned in some studies [9–11], a clear epidemi-
ological association exists between PVL production and suc-
cessful CA-MRSA lineages [1,3,12–15].
PVL was ﬁrst described in 1932 and is a two-component
pore-forming cytotoxin that was initially considered to be
associated with skin and soft tissue infections [15,16]. PVL is
carried by approximately 2% of S. aureus isolates and is
encoded by two co-transcribed genes, lukS-PV and lukF-PV,
located on lysogenized bacteriophages [17,18]. Six PVL-
encoding phages have been described in S. aureus with two
distinct morphologies: icosahedral head type (FPVL and
F108PVL) or elongated head type (FSLT, FSa2mw,
FSa2958 and FSa2usa) [19–21]. Ma et al. [19] recently
reported a PCR-based scheme for characterizing PVL-encod-
ing phages in S. aureus. Analysis of a collection of clinical
isolates dating back to 1975 demonstrated that two
PVL-encoding phages (FPVL and FSa2958) predominate
among Japanese MRSA [19]. Although the sequence of the
PVL genes is well conserved, single nucleotide polymor-
phisms (SNPs) in the PVL genes tend to vary according to
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lineage, and two variants of the PVL proteins have been
described, which may have functional implications [7,22–25].
We recently reported the emergence of CA-MRSA at a
London teaching hospital with increases in both the number
of ciproﬂoxacin-susceptible MRSA and the proportion of
recovered MRSA isolates that were PVL-positive [13]. We
hypothesized that polymorphisms in the PVL genes would
vary with the PVL-encoding phage. In the present study, we
analysed PVL-positive isolates from our hospital in detail to
determine whether polymorphisms in PVL gene sequence
and the PVL-encoding phage vary with lineage.
Materials and methods
Bacterial isolates
Twenty-two PVL-positive clinical MRSA isolates reported
previously were selected to reﬂect the multilocus sequence
type (MLST) clonal complexes (CC) identiﬁed, namely CC1,
5, 8, 59, 80, 88 and ST154 (CC30 isolates were not reported
in our hospital during the study period) [13]. CC80 was the
predominant PVL-positive clone reported. Accordingly, one
representative PVL-positive CC80 isolate was chosen from
each year of the study [13]. Genome sequence data for
strains MW2 [26] and USA300 [21] were analysed and two
PVL-positive t127 clinical isolates from the Staphylococcus
Reference Unit (HPA Colindale, London) collection were
included for study and comparison.
Characterization of PVL-MRSA isolates
Conﬁrmed clinical isolates of S. aureus were tested for anti-
microbial susceptibility using automated broth microdilution
(Vitek 2; bioMe´rieux, Basingstoke, UK). A D-test for induc-
ible clindamycin resistance was performed using standard
methods. The oxacillin MIC was determined using Etest
strips (AB BIODISK, Solna, Sweden).
DNA was extracted using the ChargeSwitch gDNA mini-
bacteria kit (Invitrogen Ltd, Paisley, UK). Isolates were char-
acterized by SCCmec [27,28] and spa type, pulsed-ﬁeld gel
electrophoresis (PFGE) proﬁle and MLST, as described previ-
ously [13]. spa types were clustered into related CCs using
the Based Upon Repeat Patterns (BURP) algorithm with a
calculated cost between members of £4, as described previ-
ously [13]. Cluster analysis was performed on the basis of
PFGE proﬁles using BioNumerics software (Applied Maths,
Sint-Martens-Latem, Belgium), as described by Strommenger
et al. [29]. A similarity cut-off of 80% was used to deﬁne a
cluster. Differing pulsotypes within a cluster were assigned
unique cluster numbers; indistinguishable isolates were
assigned the same number.
PVL gene sequencing and phage identiﬁcation
Primers to amplify and to determine the sequence of the
1918 bp lukSF-PV genes were designed based on the genome
sequence of strain USA300 [21] (Table 1). All PCRs were
performed on a Dyad DNA Engine Peltier Thermal Cycler
(Bio-Rad, Hemel Hempstead, UK). For ampliﬁcation of the
PVL genes, PCR reaction mixtures contained 0.3 lM of
primers P1F and P1R (Table 1), 1· AccuPrime Pfx Reaction
mix, 1 U AccuPrime Pfx DNA polymerase and 2 lL of
extracted DNA in 50 lL reaction volumes (Invitrogen Ltd).
PCR conditions were: 94C for 2 min, 35 cycles of 95C for
15 s, 55C for 30 s and 68C for 2 min. PCR products were
sequenced using each of the primers described in Table 1
(GATC BioTech AG, Konstanz, Germany).
Eight PCRs were performed to determine the PVL-encod-
ing phage, using primers described by Ma et al. [19]. The
sequence of primer teilE-F2 for PCR4 (5¢- ATT-
GATTCAAACTGTTTCTTCTCAGGA-3¢), which was not
included by Ma et al. [19], was kindly communicated by the
authors. PCR reactions 1, 2, 5, 6 and 7 contained 0.2 lM of
each primer, 1· Platinum Taq ampliﬁcation buffer, 0.4 mM of
each dNTP, 1.5 mM MgCl2, 4 U Platinum Taq DNA poly-
merase and 2 lL of extracted DNA in 50 lL reaction vol-
umes (Invitrogen Ltd). PCR conditions were: 94C for 4 min,
30 cycles of 95C for 60 s, 50C for 60 s and 72C for
4.5 min. PCR reactions 3, 4 and 8 contained 0.4 lM of each
primer, 1· LongRange PCR buffer, 0.5 mM of each dNTP,
2 U LongRange PCR enzyme mix and 2 lL of extracted
DNA in 50 lL reaction volumes (Qiagen, Crawley, UK).
PCR conditions were: 93C for 3 min followed by 35 cycles
of 93C for 15 s, 55C for 30 s and 68C for 10.5 min. PCR
products were visualized on 1.5% agarose gels containing
0.4 mg/L ethidium bromide.
Results
The detailed characteristics of the 22 isolates are summa-
rized in Table 2. All isolates were mecA positive but ﬁve
TABLE 1. Primers used to sequence the Panton–Valentine
leukocin (PVL) genes with primers designed based on the
sequence of the PVL genes in strain USA300 [21]
Name Sequence (5¢- to 3¢)
Location of
primers in lukSF-PV
P1F GTATGCAAAAAAAGACTATTAG 1–22
P1R GAAAAAAATCCTATGAGCTAA 1897–1918
P2F TAGTCAAAATCCGAGAGAC 635–654
P2R TTTATTGGGGTTCTAAGTAC 1238–1258
P3F GACTCAGTAAACGTTGTAG 1285–1304
P3R GTAAAATGTCTGGACATGA 586–605
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isolates were oxacillin-susceptible according to Etest (range
0.25–1 mg/L). Two of these isolates (isolate IDs 13 and 17)
were oxacillin-resistant (MIC ‡4 mg/L) as determined with
Vitek 2. The 22 isolates clustered similarly based on MLST,
PFGE proﬁle and spa type (Table 2). PVL gene sequence
data showed SNPs at seven locations in lukSF-PV; one was
nonsynonymous. Phylogenetic analyses by both Takano et al.
[7] and Wolter et al. [24] propose the FSLT/ST30 gene
sequence as the progenitor lukSF-PV sequence. Therefore,
we compared the SNP proﬁles in our isolates with that in
FSLT.
Two isolates belonged to MLST CC1. The t128 isolate
(isolate ID 6) carried FSa2mw and had PVL genes homolo-
gous to those of strain USA400. The t127 isolate (isolate ID
20) had PVL genes homologous to those of strain USA300
but the PVL-encoding phage could not be identiﬁed because
PCRs 3 and 4 to identify the linkage between the phage and
the PVL genes were negative [19]. Two randomly selected
t127 isolates obtained from the national Staphylococcus Refer-
ence Unit (London) both had PVL genes homologous to
those of USA300. The PVL-encoding phage in one of these
isolates could not be identiﬁed and the other appeared to
carry FPVL (data not shown). However, the PCR for FPVL
lacked speciﬁcity, with 20/22 isolates yielding the FPVL band
in PCR5; BLAST analysis of these primers showed poor
speciﬁcity, demonstrating 100% sequence identity with the
PVL genes from FSa2usa and F2958.
The ST5 isolate had the same PVL gene SNP proﬁle as
FSLT and all PVL phage PCR reactions were negative, sug-
gesting the isolate harboured a novel PVL-encoding phage.
Six isolates belonged to MLST CC8. Three were SCCmec
IVa and three were SCCmec IVc. All six CC8 isolates had
PVL genes homologous with those of USA300 and contained
elongated-head type PVL-encoding phages. Primers to detect
FSa2usa, the PVL-encoding phage in USA300 [21], were not
included in the assay described by Ma et al. [19].
Three of the isolates were CC59 and had one silent SNP
compared to FSLT. Both multidrug-resistant isolates possibly
carried a variant of FSa2958 because PCR6 (speciﬁc for
FSa2958) was positive; however, PCR4, designed to detect
the linkage between the phage and the PVL genes, was nega-
tive. The PVL-encoding phage in the nonresistant CC59 iso-
late could not be determined.
Seven CC80 ‘European’ clone isolates were included for
study. Six were SCCmec IVc, one was SCCmec IVa and all
were within a single spa repeat change of t044 with
related PFGE proﬁles. The PVL genes in all CC80 isolates
had two silent SNPs compared to FSLT, and all isolates
carried FSa2mw, the PVL-encoding phage present in
USA400 [26].
The two CC88 isolates had two silent SNPs in the
PVL genes compared to FSLT and carried an elongated
head-type, PVL-encoding phage, which was not identiﬁed
deﬁnitively.
The ST154 isolate was identiﬁed as belonging to a dis-
tinct lineage by MLST and PFGE analysis, but incorrectly
clustered with the CC80 isolates by BURP analysis of spa
types. The PVL gene in this isolate had two silent SNPs
compared to that of FSLT and contained an elongated
head-type, PVL-encoding phage, as did the MLST CC8 and
CC88 isolates.
Discussion
Analysis of 22 clinical isolates of CA-MRSA from London
showed that the PVL-encoding phage and the DNA sequence
of PVL genes varied with lineage. The young age of the
affected patients as well as the often low-level expression of
oxacillin resistance and non-multidrug-resistant phenotype
are consistent with CA-MRSA [4,30]. Antimicrobial resis-
tance and SCCmec type were variable within lineages, most
likely as a result of the loss or acquisition of mobile genetic
elements [31].
Despite epidemiological and some clinical evidence linking
PVL with CA-MRSA infections [1,3,15], debate exists over
the role of PVL, not least because of conﬂicting data from in
vitro animal models [9,11,14,32–34]. Sequence variation in
the PVL genes may have structural and functional implica-
tions: a nonsynonymous SNP resulting in an amino acid
change from histidine (H) (‘H’ type) to arginine (R) (‘R’ type)
in LukS-PV has been identiﬁed [22,35]. The R and H PVL
types have comparable biological activity on human PMNs in
vitro [23] but, although the H type was present in a wide
variety of successful CA-MRSA lineages [7,24], the R haplo-
type was found only in USA300 and USA400 isolates. This
striking ﬁnding was mirrored in the present study, where it
was strictly associated with MLST CC1 and CC8 isolates
[7,23,24]. However, the R haplotype has been identiﬁed in
an ST93 ‘Queensland’ CA-MRSA clone, and is not exclusive
to CC1 and CC8 [36].
To monitor the distribution and spread of the PVL-encod-
ing phages, Ma et al. [19] developed a PCR-based scheme. It
is important to note that this algorithmic approach to detect
various phage structures in a series of PCR reactions could
result in misleading ﬁndings because S. aureus can carry mul-
tiple lysogenized phages [20]. To address this problem, the
scheme includes reactions to detect linkage regions between
the phage and the PVL genes, but the linkage region, if
detected, is not necessarily associated with the same phage.
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In the present study, the CC8 and CC80 isolates were
positive with both PCR1 and PCR2, indicating the presence
of both icosahedral and elongated-head type phages. PCR4
(speciﬁc for the linkage region between elongated head-type
phages and the PVL genes) was also positive, suggesting the
presence of a PVL-encoding elongated head-type phage.
However, the linkage reactions were negative for ﬁve of the
22 clinical isolates tested, limiting the utility of the assay and
suggesting the presence of variant or even novel PVL-encod-
ing phages, which is consistent with the ﬁndings of Ma et al.
[19]. In addition, the observed poor speciﬁcity of one of the
primers reported by Ma et al. [19] means that the identiﬁca-
tion of a 1411 bp fragment in the multiplex PCR5 reaction
should not be used, a priori, to infer the presence of FPVL,
but rather, can be used as part of the prescribed algorithmic
approach.
Seven SNPs were identiﬁed in lukSF-PV, which tended to
vary according to lineage and which correlated with the PVL-
encoding phage in the clinical isolates [7,22–24]. Despite
intra-lineage variations in SCCmec type, particularly in our
MLST CC8, 80 and 88 isolates, the PVL gene sequence and
phage were identical. However, several different phage types
were noted in CC1 and CC59 isolates. It was striking that
the two multidrug-resistant CC59 isolates carried apparently
the same phage, whereas the non-multidrug-resistant CC59
isolate appeared to carry a different phage, despite having
the same SNP proﬁle. Similarly, SNP proﬁle and phage in
CC1 isolates appeared to vary with clone: t128 isolates are
usually PVL-positive, whereas t127 isolates are usually PVL-
negative [13], so the t127 CC1 isolates and t128 CC1 iso-
lates represent different sub-types of CC1 PVL-MRSA.
Therefore, it appears likely that the PVL sequence and phage
varies with the clone. However, given the small number of
isolates from each lineage in the present study, and the dis-
covery of variation in the PVL SNP proﬁle within lineages in
other studies [22,36], further work is required to conﬁrm
this ﬁnding.
From an evolutionary perspective, these data support the
notion that PVL-encoding phages initially infected MSSA, and
some subsequently acquired SCCmec to give rise to PVL-
positive CA-MRSA [22,24]. The ﬁnding of MSSA and MRSA
with identical SNP proﬁles also supports this model [22,23].
In summary, PVL gene sequence and the PVL-encoding
phage vary with lineage in PVL-positive CA-MRSA. Further
work is needed to understand the reasons for the partner-
ship between polymorphisms in the PVL genes and the
PVL-encoding phage, and whether these polymorphisms have
clinical signiﬁcance. Investigation of the PVL gene sequence
and phage type in other CA-MRSA of the same lineage, or in
older versions of the same lineage, and in related MSSA,
would shed further light on the population biology of
PVL-positive S. aureus.
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